Tag: Leukemia
Cellectis: UCART22 has been administered to a first patient for the treatment of acute lymphoblastic leukemia
(Boursier.com) — Cellectis a clinical-stage biotechnology company that uses its pioneering TALEN genome-editing technology to develop innovative therapies for the treatment of serious diseases, today announces that its in-house manufactured…
Cellectis: first patient treated in leukemia – 23/12/2022 at 11:40
(CercleFinance.com) – Cellectis announced on Friday that its product candidate UCART22 had been administered to a first patient as part of a study dedicated to the treatment of acute lymphoblastic…
Cellectis: first patient treated in leukemia
(CercleFinance.com) – Cellectis announced on Friday that its product candidate UCART22 had been administered to a first patient as part of a study dedicated to the treatment of acute lymphoblastic…
OSE Immunotherapeutics presents the latest preclinical efficacy data of its IL-7 receptor antagonist OSE-127 in acute lymphoblastic leukemia at the 2022 ASH Annual Meeting – 12/12/2022 at 07:30
Nantes, France – December 12, 2022, 7:30 a.m. – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) presented the latest preclinical data on the use of its IL-7 receptor antagonist (IL-7R)…
Nicolas Peyrac: Leukemia, autoimmune disease and transfusions … the singer finally gives his news
Lost of old? Never ! On June 2, 2022, Nicolas Peyrac released, not a new album, but his 4th unpublished novel, entitled Without forgetting that one day we loved each…
“My cancer is too aggressive”: Tim Lobinger has no chance of healing
“My cancer is too aggressive” Tim Lobinger has no chance of healing 10/04/2022 8:44 am Tim Lobinger will lose the fight against cancer, the doctors have told him. A heavy…
Novartis: The EU has approved a treatment for leukemia
Receive the value of the day selected by The data collected is essential for this processing and is intended for the relevant departments of BFM Bourse and, where applicable, its…
Erytech pharma: The biotech Erytech gives up its treatment against leukemia and falls on the stock market
(BFM Bourse) – The Lyon-based company has decided to no longer seek approval from the US health authority for a potential treatment for acute lymphoblastic leukemia. The company is weighing…
Aggressive Leukemia – Baby Elias urgently needs a stem cell donation
Mama Melina and Papa Severin drove to the hospital with their sunshine Elias (seven months) with stomach ache. The doctors couldn’t find anything and sent her back home. A month…
Fight against leukemia: – lifesaver appeals for donations in Linz
Words of thanks from the rescuedJust like Nina Hocheneder from Linz, who became a lifesaver for a Swiss woman in 2021! “When I found out that my donation was appropriate,…
Novartis: Swissmedic authorizes treatment for leukemia
Zurich (awp) – Novartis has obtained approval from the Swiss Institute for Therapeutic Products (Swissmedic) for its new treatment Scemblix (asciminib), in the indication against chronic myeloid leukemia (CML), after…
Novartis presents positive data with Kymriah (leukemia)
Zurich (awp) – Novartis on Sunday published positive results from a study of Kymriah in the treatment of relapsed or refractory acute lymphatic leukemia in children and young adults. The…